Provided by Tiger Trade Technology Pte. Ltd.

Global Partners LP

44.37
-0.6300-1.40%
Post-market: 44.370.00000.00%16:10 EDT
Volume:34.12K
Turnover:1.51M
Market Cap:1.51B
PE:21.03
High:44.84
Open:44.46
Low:44.00
Close:45.00
52wk High:56.59
52wk Low:39.58
Shares:34.00M
Float Shares:27.67M
Volume Ratio:0.42
T/O Rate:0.12%
Dividend:3.01
Dividend Rate:6.78%
EPS(TTM):2.11
EPS(LYR):2.11
ROE:14.08%
ROA:3.79%
PB:2.52
PE(LYR):21.03

Loading ...

BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs

GlobeNewswire
·
Feb 24

SureNano Buys GlucaPharm to Drive Next-Generation GLP-1 Drug Push

TIPRANKS
·
Feb 23

GLP J-REIT to Acquire Sixth Preferred Securities for 158 Million Yen

MT Newswires Live
·
Feb 20

Earning Preview: Global Partners LP Q4 revenue is expected to increase by 19.55%, and institutional views are mixed

Earnings Agent
·
Feb 20

McDonald's Tests GLP-1 Friendly Menu While Deepening Cultural Relevance

Simply Wall St.
·
Feb 19

CollPlant Moves to Capture GLP-1-Driven Aesthetic Market With Photocurable rhCollagen Filler

TIPRANKS
·
Feb 17

CSPC PHARMA's Long-Acting GLP-1/GIP Dual Agonist Receives FDA Clearance for US Clinical Trials

Stock News
·
Feb 16

CSPC Wins U.S. FDA Nod for Monthly GLP-1/GIP Obesity Injection Trial

TIPRANKS
·
Feb 16

Biophytis Targets Muscle Loss in GLP-1 Weight Loss Users With New Phase 2 Trial

TIPRANKS
·
Feb 14

Buy Rating on West: Strong Non‑GLP‑1 Growth, Margin Expansion, and Regulatory Tailwinds Support 2026 Outlook

TIPRANKS
·
Feb 13

West Pharmaceutical: Strong Quarterly Beat and Confident 2026 Outlook Support Buy Rating Despite GLP‑1 Concerns

TIPRANKS
·
Feb 12

Global Partners LP to Announce Fourth-Quarter and Full-Year 2025 Financial Results

Reuters
·
Feb 12

McDonald's Tests High Protein Menu As GLP-1 Weight-Loss Drug Users Surge

Benzinga_recent_news
·
Feb 12

Veru Inc. Charts Risky but Clearer Post-GLP-1 Path

TIPRANKS
·
Feb 12

Edible Garden to Introduce Clean-Label JEALOUSY GLP-1 Support System and New Kick. Sports Nutrition® Innovations at ECRM Total Wellness Session

GlobeNewswire
·
Feb 11

Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era

GlobeNewswire
·
Feb 10

Regulatory Overhang on Compounded GLP‑1 Drives Hold Rating and Lowered Outlook for Hims & Hers

TIPRANKS
·
Feb 09

Dow Jones Top Company Headlines at 1 AM ET: Health Agency Refers Knockoff GLP-1 Provider Hims & Hers to Justice Department | Innovent ...

Dow Jones
·
Feb 09

Dow Jones Top Company Headlines at 7 PM ET: FDA Targets Hims & Hers, Other Marketers of Unapproved GLP-1 Weight-Loss Drugs | Justice ...

Dow Jones
·
Feb 07

FDA intends to ‘take action’ against non-FDA-approved GLP-1 drugs

TIPRANKS
·
Feb 07